Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Phase III KEYNOTE-590 study of chemotherapy plus pembrolizumab versus chemotherapy plus placebo as first-line therapy for patients (Pts) with advanced esophageal or esophagogastric junction (E/EGJ) cancer
- Authors
- Kato, K[Kato, K.]; Shah, MA[Shah, M. A.]; Enzinger, PC[Enzinger, P. C.]; Bennouna, J[Bennouna, J.]; Shen, L[Shen, L.]; Adenis, A[Adenis, A.]; Sun, JM[Sun, J-M.]; Cho, BC[Cho, B. C.]; Ozguroglu, M[Ozguroglu, M.]; Kojima, T[Kojima, T.]; Kostorov, V[Kostorov, V.]; Hierro, C[Hierro, C.]; Zhu, Y[Zhu, Y.]; Shah, S[Shah, S.]; Bhagia, P[Bhagia, P.]; Doi, T[Doi, T.]
- Issue Date
- Oct-2018
- Publisher
- OXFORD UNIV PRESS
- Citation
- ANNALS OF ONCOLOGY, v.29
- Indexed
- SCIE
SCOPUS
- Journal Title
- ANNALS OF ONCOLOGY
- Volume
- 29
- ISSN
- 0923-7534
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.